iShares Health Innovation Active ETF BMED

Morningstar Medalist Rating

Morningstar’s Analysis BMED

Will BMED outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BMED

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings44.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Gilead Sciences Inc

5.83845,947
Healthcare

Moderna Inc

5.35776,434
Healthcare

Danaher Corp

5.19753,121
Healthcare

BlackRock Cash Funds Treasury SL Agency

4.96720,000
Cash and Equivalents

AbbVie Inc

4.94717,218
Healthcare

Thermo Fisher Scientific Inc

4.35631,598
Healthcare

Edwards Lifesciences Corp

4.32626,399
Healthcare

Biogen Inc

3.75544,810
Healthcare

Mettler-Toledo International Inc

3.64528,629
Healthcare

IQVIA Holdings Inc

3.51509,826
Healthcare

Sponsor Center